Global Organ and Tissue Transplantation and Alternative Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 13 Feb 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Organ and Tissue Transplantation and Alternative market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Organ transplantation as a therapeutic strategy for patients with end-stage organ disease have been achieved due to greater insight into the immunobiology of graft rejection and better measures for surgical and medical management.

This report studies the global Organ and Tissue Transplantation and Alternative production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Organ and Tissue Transplantation and Alternative, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Organ and Tissue Transplantation and Alternative that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Organ and Tissue Transplantation and Alternative total production and demand, 2018-2029, (K Units)
Global Organ and Tissue Transplantation and Alternative total production value, 2018-2029, (USD Million)
Global Organ and Tissue Transplantation and Alternative production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Organ and Tissue Transplantation and Alternative consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Organ and Tissue Transplantation and Alternative domestic production, consumption, key domestic manufacturers and share
Global Organ and Tissue Transplantation and Alternative production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Organ and Tissue Transplantation and Alternative production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Organ and Tissue Transplantation and Alternative production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Organ and Tissue Transplantation and Alternative market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Arthrex, Biomet, Bristol-Myers, Centacor, CryoLife, Inc., Dr. Franz Köhler Chemie GmbH, Novartis and Organ Transport Systems, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Organ and Tissue Transplantation and Alternative market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Organ and Tissue Transplantation and Alternative Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Organ and Tissue Transplantation and Alternative Market, Segmentation by Type
    Organ Transplantation
    Tissue Transplantation
    Cell Transplantation

Global Organ and Tissue Transplantation and Alternative Market, Segmentation by Application
    Hospital
    Clinic
    Laboratory

Companies Profiled:
    Abbott
    Arthrex
    Biomet
    Bristol-Myers
    Centacor
    CryoLife, Inc.
    Dr. Franz Köhler Chemie GmbH
    Novartis
    Organ Transport Systems
    Organogenesis, Inc.
    XVIVO Perfusion AB

Key Questions Answered
1. How big is the global Organ and Tissue Transplantation and Alternative market?
2. What is the demand of the global Organ and Tissue Transplantation and Alternative market?
3. What is the year over year growth of the global Organ and Tissue Transplantation and Alternative market?
4. What is the production and production value of the global Organ and Tissue Transplantation and Alternative market?
5. Who are the key producers in the global Organ and Tissue Transplantation and Alternative market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Organ and Tissue Transplantation and Alternative Introduction
    1.2 World Organ and Tissue Transplantation and Alternative Supply & Forecast
        1.2.1 World Organ and Tissue Transplantation and Alternative Production Value (2018 & 2022 & 2029)
        1.2.2 World Organ and Tissue Transplantation and Alternative Production (2018-2029)
        1.2.3 World Organ and Tissue Transplantation and Alternative Pricing Trends (2018-2029)
    1.3 World Organ and Tissue Transplantation and Alternative Production by Region (Based on Production Site)
        1.3.1 World Organ and Tissue Transplantation and Alternative Production Value by Region (2018-2029)
        1.3.2 World Organ and Tissue Transplantation and Alternative Production by Region (2018-2029)
        1.3.3 World Organ and Tissue Transplantation and Alternative Average Price by Region (2018-2029)
        1.3.4 North America Organ and Tissue Transplantation and Alternative Production (2018-2029)
        1.3.5 Europe Organ and Tissue Transplantation and Alternative Production (2018-2029)
        1.3.6 China Organ and Tissue Transplantation and Alternative Production (2018-2029)
        1.3.7 Japan Organ and Tissue Transplantation and Alternative Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Organ and Tissue Transplantation and Alternative Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Organ and Tissue Transplantation and Alternative Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Organ and Tissue Transplantation and Alternative Demand (2018-2029)
    2.2 World Organ and Tissue Transplantation and Alternative Consumption by Region
        2.2.1 World Organ and Tissue Transplantation and Alternative Consumption by Region (2018-2023)
        2.2.2 World Organ and Tissue Transplantation and Alternative Consumption Forecast by Region (2024-2029)
    2.3 United States Organ and Tissue Transplantation and Alternative Consumption (2018-2029)
    2.4 China Organ and Tissue Transplantation and Alternative Consumption (2018-2029)
    2.5 Europe Organ and Tissue Transplantation and Alternative Consumption (2018-2029)
    2.6 Japan Organ and Tissue Transplantation and Alternative Consumption (2018-2029)
    2.7 South Korea Organ and Tissue Transplantation and Alternative Consumption (2018-2029)
    2.8 ASEAN Organ and Tissue Transplantation and Alternative Consumption (2018-2029)
    2.9 India Organ and Tissue Transplantation and Alternative Consumption (2018-2029)

3 World Organ and Tissue Transplantation and Alternative Manufacturers Competitive Analysis
    3.1 World Organ and Tissue Transplantation and Alternative Production Value by Manufacturer (2018-2023)
    3.2 World Organ and Tissue Transplantation and Alternative Production by Manufacturer (2018-2023)
    3.3 World Organ and Tissue Transplantation and Alternative Average Price by Manufacturer (2018-2023)
    3.4 Organ and Tissue Transplantation and Alternative Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Organ and Tissue Transplantation and Alternative Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Organ and Tissue Transplantation and Alternative in 2022
        3.5.3 Global Concentration Ratios (CR8) for Organ and Tissue Transplantation and Alternative in 2022
    3.6 Organ and Tissue Transplantation and Alternative Market: Overall Company Footprint Analysis
        3.6.1 Organ and Tissue Transplantation and Alternative Market: Region Footprint
        3.6.2 Organ and Tissue Transplantation and Alternative Market: Company Product Type Footprint
        3.6.3 Organ and Tissue Transplantation and Alternative Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Organ and Tissue Transplantation and Alternative Production Value Comparison
        4.1.1 United States VS China: Organ and Tissue Transplantation and Alternative Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Organ and Tissue Transplantation and Alternative Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Organ and Tissue Transplantation and Alternative Production Comparison
        4.2.1 United States VS China: Organ and Tissue Transplantation and Alternative Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Organ and Tissue Transplantation and Alternative Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Organ and Tissue Transplantation and Alternative Consumption Comparison
        4.3.1 United States VS China: Organ and Tissue Transplantation and Alternative Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Organ and Tissue Transplantation and Alternative Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Organ and Tissue Transplantation and Alternative Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Organ and Tissue Transplantation and Alternative Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Organ and Tissue Transplantation and Alternative Production (2018-2023)
    4.5 China Based Organ and Tissue Transplantation and Alternative Manufacturers and Market Share
        4.5.1 China Based Organ and Tissue Transplantation and Alternative Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value (2018-2023)
        4.5.3 China Based Manufacturers Organ and Tissue Transplantation and Alternative Production (2018-2023)
    4.6 Rest of World Based Organ and Tissue Transplantation and Alternative Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Organ and Tissue Transplantation and Alternative Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Organ and Tissue Transplantation and Alternative Production (2018-2023)

5 Market Analysis by Type
    5.1 World Organ and Tissue Transplantation and Alternative Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Organ Transplantation
        5.2.2 Tissue Transplantation
        5.2.3 Cell Transplantation
    5.3 Market Segment by Type
        5.3.1 World Organ and Tissue Transplantation and Alternative Production by Type (2018-2029)
        5.3.2 World Organ and Tissue Transplantation and Alternative Production Value by Type (2018-2029)
        5.3.3 World Organ and Tissue Transplantation and Alternative Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Organ and Tissue Transplantation and Alternative Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Laboratory
    6.3 Market Segment by Application
        6.3.1 World Organ and Tissue Transplantation and Alternative Production by Application (2018-2029)
        6.3.2 World Organ and Tissue Transplantation and Alternative Production Value by Application (2018-2029)
        6.3.3 World Organ and Tissue Transplantation and Alternative Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Details
        7.1.2 Abbott Major Business
        7.1.3 Abbott Organ and Tissue Transplantation and Alternative Product and Services
        7.1.4 Abbott Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Abbott Recent Developments/Updates
        7.1.6 Abbott Competitive Strengths & Weaknesses
    7.2 Arthrex
        7.2.1 Arthrex Details
        7.2.2 Arthrex Major Business
        7.2.3 Arthrex Organ and Tissue Transplantation and Alternative Product and Services
        7.2.4 Arthrex Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Arthrex Recent Developments/Updates
        7.2.6 Arthrex Competitive Strengths & Weaknesses
    7.3 Biomet
        7.3.1 Biomet Details
        7.3.2 Biomet Major Business
        7.3.3 Biomet Organ and Tissue Transplantation and Alternative Product and Services
        7.3.4 Biomet Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Biomet Recent Developments/Updates
        7.3.6 Biomet Competitive Strengths & Weaknesses
    7.4 Bristol-Myers
        7.4.1 Bristol-Myers Details
        7.4.2 Bristol-Myers Major Business
        7.4.3 Bristol-Myers Organ and Tissue Transplantation and Alternative Product and Services
        7.4.4 Bristol-Myers Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Bristol-Myers Recent Developments/Updates
        7.4.6 Bristol-Myers Competitive Strengths & Weaknesses
    7.5 Centacor
        7.5.1 Centacor Details
        7.5.2 Centacor Major Business
        7.5.3 Centacor Organ and Tissue Transplantation and Alternative Product and Services
        7.5.4 Centacor Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Centacor Recent Developments/Updates
        7.5.6 Centacor Competitive Strengths & Weaknesses
    7.6 CryoLife, Inc.
        7.6.1 CryoLife, Inc. Details
        7.6.2 CryoLife, Inc. Major Business
        7.6.3 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Product and Services
        7.6.4 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 CryoLife, Inc. Recent Developments/Updates
        7.6.6 CryoLife, Inc. Competitive Strengths & Weaknesses
    7.7 Dr. Franz Köhler Chemie GmbH
        7.7.1 Dr. Franz Köhler Chemie GmbH Details
        7.7.2 Dr. Franz Köhler Chemie GmbH Major Business
        7.7.3 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Product and Services
        7.7.4 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Dr. Franz Köhler Chemie GmbH Recent Developments/Updates
        7.7.6 Dr. Franz Köhler Chemie GmbH Competitive Strengths & Weaknesses
    7.8 Novartis
        7.8.1 Novartis Details
        7.8.2 Novartis Major Business
        7.8.3 Novartis Organ and Tissue Transplantation and Alternative Product and Services
        7.8.4 Novartis Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Novartis Recent Developments/Updates
        7.8.6 Novartis Competitive Strengths & Weaknesses
    7.9 Organ Transport Systems
        7.9.1 Organ Transport Systems Details
        7.9.2 Organ Transport Systems Major Business
        7.9.3 Organ Transport Systems Organ and Tissue Transplantation and Alternative Product and Services
        7.9.4 Organ Transport Systems Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Organ Transport Systems Recent Developments/Updates
        7.9.6 Organ Transport Systems Competitive Strengths & Weaknesses
    7.10 Organogenesis, Inc.
        7.10.1 Organogenesis, Inc. Details
        7.10.2 Organogenesis, Inc. Major Business
        7.10.3 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Product and Services
        7.10.4 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Organogenesis, Inc. Recent Developments/Updates
        7.10.6 Organogenesis, Inc. Competitive Strengths & Weaknesses
    7.11 XVIVO Perfusion AB
        7.11.1 XVIVO Perfusion AB Details
        7.11.2 XVIVO Perfusion AB Major Business
        7.11.3 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Product and Services
        7.11.4 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 XVIVO Perfusion AB Recent Developments/Updates
        7.11.6 XVIVO Perfusion AB Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Organ and Tissue Transplantation and Alternative Industry Chain
    8.2 Organ and Tissue Transplantation and Alternative Upstream Analysis
        8.2.1 Organ and Tissue Transplantation and Alternative Core Raw Materials
        8.2.2 Main Manufacturers of Organ and Tissue Transplantation and Alternative Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Organ and Tissue Transplantation and Alternative Production Mode
    8.6 Organ and Tissue Transplantation and Alternative Procurement Model
    8.7 Organ and Tissue Transplantation and Alternative Industry Sales Model and Sales Channels
        8.7.1 Organ and Tissue Transplantation and Alternative Sales Model
        8.7.2 Organ and Tissue Transplantation and Alternative Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Organ and Tissue Transplantation and Alternative Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Organ and Tissue Transplantation and Alternative Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Organ and Tissue Transplantation and Alternative Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Organ and Tissue Transplantation and Alternative Production Value Market Share by Region (2018-2023)
    Table 5. World Organ and Tissue Transplantation and Alternative Production Value Market Share by Region (2024-2029)
    Table 6. World Organ and Tissue Transplantation and Alternative Production by Region (2018-2023) & (K Units)
    Table 7. World Organ and Tissue Transplantation and Alternative Production by Region (2024-2029) & (K Units)
    Table 8. World Organ and Tissue Transplantation and Alternative Production Market Share by Region (2018-2023)
    Table 9. World Organ and Tissue Transplantation and Alternative Production Market Share by Region (2024-2029)
    Table 10. World Organ and Tissue Transplantation and Alternative Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Organ and Tissue Transplantation and Alternative Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Organ and Tissue Transplantation and Alternative Major Market Trends
    Table 13. World Organ and Tissue Transplantation and Alternative Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Organ and Tissue Transplantation and Alternative Consumption by Region (2018-2023) & (K Units)
    Table 15. World Organ and Tissue Transplantation and Alternative Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Organ and Tissue Transplantation and Alternative Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Organ and Tissue Transplantation and Alternative Producers in 2022
    Table 18. World Organ and Tissue Transplantation and Alternative Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Organ and Tissue Transplantation and Alternative Producers in 2022
    Table 20. World Organ and Tissue Transplantation and Alternative Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Organ and Tissue Transplantation and Alternative Company Evaluation Quadrant
    Table 22. World Organ and Tissue Transplantation and Alternative Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Organ and Tissue Transplantation and Alternative Production Site of Key Manufacturer
    Table 24. Organ and Tissue Transplantation and Alternative Market: Company Product Type Footprint
    Table 25. Organ and Tissue Transplantation and Alternative Market: Company Product Application Footprint
    Table 26. Organ and Tissue Transplantation and Alternative Competitive Factors
    Table 27. Organ and Tissue Transplantation and Alternative New Entrant and Capacity Expansion Plans
    Table 28. Organ and Tissue Transplantation and Alternative Mergers & Acquisitions Activity
    Table 29. United States VS China Organ and Tissue Transplantation and Alternative Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Organ and Tissue Transplantation and Alternative Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Organ and Tissue Transplantation and Alternative Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Organ and Tissue Transplantation and Alternative Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Organ and Tissue Transplantation and Alternative Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Organ and Tissue Transplantation and Alternative Production Market Share (2018-2023)
    Table 37. China Based Organ and Tissue Transplantation and Alternative Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Organ and Tissue Transplantation and Alternative Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Organ and Tissue Transplantation and Alternative Production Market Share (2018-2023)
    Table 42. Rest of World Based Organ and Tissue Transplantation and Alternative Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Organ and Tissue Transplantation and Alternative Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Organ and Tissue Transplantation and Alternative Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Organ and Tissue Transplantation and Alternative Production Market Share (2018-2023)
    Table 47. World Organ and Tissue Transplantation and Alternative Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Organ and Tissue Transplantation and Alternative Production by Type (2018-2023) & (K Units)
    Table 49. World Organ and Tissue Transplantation and Alternative Production by Type (2024-2029) & (K Units)
    Table 50. World Organ and Tissue Transplantation and Alternative Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Organ and Tissue Transplantation and Alternative Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Organ and Tissue Transplantation and Alternative Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Organ and Tissue Transplantation and Alternative Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Organ and Tissue Transplantation and Alternative Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Organ and Tissue Transplantation and Alternative Production by Application (2018-2023) & (K Units)
    Table 56. World Organ and Tissue Transplantation and Alternative Production by Application (2024-2029) & (K Units)
    Table 57. World Organ and Tissue Transplantation and Alternative Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Organ and Tissue Transplantation and Alternative Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Organ and Tissue Transplantation and Alternative Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Organ and Tissue Transplantation and Alternative Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Abbott Basic Information, Manufacturing Base and Competitors
    Table 62. Abbott Major Business
    Table 63. Abbott Organ and Tissue Transplantation and Alternative Product and Services
    Table 64. Abbott Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Abbott Recent Developments/Updates
    Table 66. Abbott Competitive Strengths & Weaknesses
    Table 67. Arthrex Basic Information, Manufacturing Base and Competitors
    Table 68. Arthrex Major Business
    Table 69. Arthrex Organ and Tissue Transplantation and Alternative Product and Services
    Table 70. Arthrex Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Arthrex Recent Developments/Updates
    Table 72. Arthrex Competitive Strengths & Weaknesses
    Table 73. Biomet Basic Information, Manufacturing Base and Competitors
    Table 74. Biomet Major Business
    Table 75. Biomet Organ and Tissue Transplantation and Alternative Product and Services
    Table 76. Biomet Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Biomet Recent Developments/Updates
    Table 78. Biomet Competitive Strengths & Weaknesses
    Table 79. Bristol-Myers Basic Information, Manufacturing Base and Competitors
    Table 80. Bristol-Myers Major Business
    Table 81. Bristol-Myers Organ and Tissue Transplantation and Alternative Product and Services
    Table 82. Bristol-Myers Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Bristol-Myers Recent Developments/Updates
    Table 84. Bristol-Myers Competitive Strengths & Weaknesses
    Table 85. Centacor Basic Information, Manufacturing Base and Competitors
    Table 86. Centacor Major Business
    Table 87. Centacor Organ and Tissue Transplantation and Alternative Product and Services
    Table 88. Centacor Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Centacor Recent Developments/Updates
    Table 90. Centacor Competitive Strengths & Weaknesses
    Table 91. CryoLife, Inc. Basic Information, Manufacturing Base and Competitors
    Table 92. CryoLife, Inc. Major Business
    Table 93. CryoLife, Inc. Organ and Tissue Transplantation and Alternative Product and Services
    Table 94. CryoLife, Inc. Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. CryoLife, Inc. Recent Developments/Updates
    Table 96. CryoLife, Inc. Competitive Strengths & Weaknesses
    Table 97. Dr. Franz Köhler Chemie GmbH Basic Information, Manufacturing Base and Competitors
    Table 98. Dr. Franz Köhler Chemie GmbH Major Business
    Table 99. Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Product and Services
    Table 100. Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Dr. Franz Köhler Chemie GmbH Recent Developments/Updates
    Table 102. Dr. Franz Köhler Chemie GmbH Competitive Strengths & Weaknesses
    Table 103. Novartis Basic Information, Manufacturing Base and Competitors
    Table 104. Novartis Major Business
    Table 105. Novartis Organ and Tissue Transplantation and Alternative Product and Services
    Table 106. Novartis Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Novartis Recent Developments/Updates
    Table 108. Novartis Competitive Strengths & Weaknesses
    Table 109. Organ Transport Systems Basic Information, Manufacturing Base and Competitors
    Table 110. Organ Transport Systems Major Business
    Table 111. Organ Transport Systems Organ and Tissue Transplantation and Alternative Product and Services
    Table 112. Organ Transport Systems Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Organ Transport Systems Recent Developments/Updates
    Table 114. Organ Transport Systems Competitive Strengths & Weaknesses
    Table 115. Organogenesis, Inc. Basic Information, Manufacturing Base and Competitors
    Table 116. Organogenesis, Inc. Major Business
    Table 117. Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Product and Services
    Table 118. Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Organogenesis, Inc. Recent Developments/Updates
    Table 120. XVIVO Perfusion AB Basic Information, Manufacturing Base and Competitors
    Table 121. XVIVO Perfusion AB Major Business
    Table 122. XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Product and Services
    Table 123. XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Organ and Tissue Transplantation and Alternative Upstream (Raw Materials)
    Table 125. Organ and Tissue Transplantation and Alternative Typical Customers
    Table 126. Organ and Tissue Transplantation and Alternative Typical Distributors
List of Figure
    Figure 1. Organ and Tissue Transplantation and Alternative Picture
    Figure 2. World Organ and Tissue Transplantation and Alternative Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Organ and Tissue Transplantation and Alternative Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Organ and Tissue Transplantation and Alternative Production (2018-2029) & (K Units)
    Figure 5. World Organ and Tissue Transplantation and Alternative Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Organ and Tissue Transplantation and Alternative Production Value Market Share by Region (2018-2029)
    Figure 7. World Organ and Tissue Transplantation and Alternative Production Market Share by Region (2018-2029)
    Figure 8. North America Organ and Tissue Transplantation and Alternative Production (2018-2029) & (K Units)
    Figure 9. Europe Organ and Tissue Transplantation and Alternative Production (2018-2029) & (K Units)
    Figure 10. China Organ and Tissue Transplantation and Alternative Production (2018-2029) & (K Units)
    Figure 11. Japan Organ and Tissue Transplantation and Alternative Production (2018-2029) & (K Units)
    Figure 12. Organ and Tissue Transplantation and Alternative Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 15. World Organ and Tissue Transplantation and Alternative Consumption Market Share by Region (2018-2029)
    Figure 16. United States Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 17. China Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 18. Europe Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 19. Japan Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 22. India Organ and Tissue Transplantation and Alternative Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Organ and Tissue Transplantation and Alternative by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Organ and Tissue Transplantation and Alternative Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Organ and Tissue Transplantation and Alternative Markets in 2022
    Figure 26. United States VS China: Organ and Tissue Transplantation and Alternative Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Organ and Tissue Transplantation and Alternative Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Organ and Tissue Transplantation and Alternative Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Organ and Tissue Transplantation and Alternative Production Market Share 2022
    Figure 30. China Based Manufacturers Organ and Tissue Transplantation and Alternative Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Organ and Tissue Transplantation and Alternative Production Market Share 2022
    Figure 32. World Organ and Tissue Transplantation and Alternative Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Organ and Tissue Transplantation and Alternative Production Value Market Share by Type in 2022
    Figure 34. Organ Transplantation
    Figure 35. Tissue Transplantation
    Figure 36. Cell Transplantation
    Figure 37. World Organ and Tissue Transplantation and Alternative Production Market Share by Type (2018-2029)
    Figure 38. World Organ and Tissue Transplantation and Alternative Production Value Market Share by Type (2018-2029)
    Figure 39. World Organ and Tissue Transplantation and Alternative Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Organ and Tissue Transplantation and Alternative Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Organ and Tissue Transplantation and Alternative Production Value Market Share by Application in 2022
    Figure 42. Hospital
    Figure 43. Clinic
    Figure 44. Laboratory
    Figure 45. World Organ and Tissue Transplantation and Alternative Production Market Share by Application (2018-2029)
    Figure 46. World Organ and Tissue Transplantation and Alternative Production Value Market Share by Application (2018-2029)
    Figure 47. World Organ and Tissue Transplantation and Alternative Average Price by Application (2018-2029) & (US$/Unit)
    Figure 48. Organ and Tissue Transplantation and Alternative Industry Chain
    Figure 49. Organ and Tissue Transplantation and Alternative Procurement Model
    Figure 50. Organ and Tissue Transplantation and Alternative Sales Model
    Figure 51. Organ and Tissue Transplantation and Alternative Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Organ and Tissue Transplantation and Alternative Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Organ and Tissue Transplantation and Alternative Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Medical Devices & Consumables

Organ transplantation as a therapeutic strategy for patients with end-stage organ disease have been achieved due to greater insight into the immunobiology of graft rejection and better measures for surgical and medical management.

Global Organ and Tissue Transplantation and Alternative Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Organ and Tissue Transplantation and Alternative Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 15 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Organ and Tissue Transplantation and Alternative market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Organ and Tissue Transplantation and Alternative

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>